Difference between revisions of "Draft4RCT"
Jump to navigation
Jump to search
(New page: ==High-Level Concepts== *Events *Periods **Study phases **Protocol phases *Sequence of events *Study designs *Research types <font style="color:blue">**Randomized Clinical Trial</font> *M...) |
m |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 7: | Line 7: | ||
*Study designs | *Study designs | ||
*Research types | *Research types | ||
| − | <font style="color:blue"> | + | **<font style="color:blue">Randomized Clinical Trial</font> |
*Methods | *Methods | ||
*Stakeholders | *Stakeholders | ||
| Line 15: | Line 15: | ||
**Sponsors | **Sponsors | ||
*Populations | *Populations | ||
| − | <font style="color:blue"> | + | **<font style="color:blue">Screened population |
**Recruited population | **Recruited population | ||
**Eligible population | **Eligible population | ||
| Line 25: | Line 25: | ||
*Variables | *Variables | ||
**Independent variable | **Independent variable | ||
| − | <font style="color:blue"> | + | ***<font style="color:blue">Intervention |
****Procedure | ****Procedure | ||
****Device implantation | ****Device implantation | ||
| Line 36: | Line 36: | ||
**Dependent variable (responding variable) | **Dependent variable (responding variable) | ||
***Outcome | ***Outcome | ||
| − | <font style="color:blue"> | + | ****<font style="color:blue">Primary outcome |
****Secondary outcome | ****Secondary outcome | ||
****Adverse event/Side effect | ****Adverse event/Side effect | ||
| Line 42: | Line 42: | ||
*Digital and paper artifacts | *Digital and paper artifacts | ||
*Protocol | *Protocol | ||
| − | <font style="color:blue"> | + | **<font style="color:blue">Intended protocol |
| − | + | **Executed protocol</font> | |
*Protocol application | *Protocol application | ||
**Assessments | **Assessments | ||
| Line 68: | Line 68: | ||
**Ratio | **Ratio | ||
*Participant characteristic (phenotype) | *Participant characteristic (phenotype) | ||
| − | <font style="color:blue"> | + | **<font style="color:blue">Baseline characteristic</font> |
Latest revision as of 11:27, 26 April 2007
High-Level Concepts
- Events
- Periods
- Study phases
- Protocol phases
- Sequence of events
- Study designs
- Research types
- Randomized Clinical Trial
- Methods
- Stakeholders
- Participants
- Investigators
- Monitors
- Sponsors
- Populations
- Screened population
- Recruited population
- Eligible population
- Enrolled population
- Randomized population
- Analysed population
- Crossover population
- Subgroup population
- Variables
- Independent variable
- Intervention
- Procedure
- Device implantation
- Drug treatment
- Placebo treatment
- Sham procedure
- Usual care
- Counseling
- Cointervention
- Intervention
- Dependent variable (responding variable)
- Outcome
- Primary outcome
- Secondary outcome
- Adverse event/Side effect
- Ancillary outcome
- Outcome
- Independent variable
- Digital and paper artifacts
- Protocol
- Intended protocol
- Executed protocol
- Protocol application
- Assessments
- Experimental assays
- Observations
- Physical exam
- Interview
- Self-assessments
- Data analysis
- Data partitioning
- Data transformation
- Data pooling
- Data summarization
- Reliability
- Correlation
- Specimen processing
- Procurement
- Specimen partitioning/purification
- Specimen storage
- Assessments
- Measurement scale
- Nominal
- Ordinal
- Interval
- Ratio
- Participant characteristic (phenotype)
- Baseline characteristic